CCG
ELV icon

Cloverfields Capital Group’s Elevance Health ELV Stock Holding History

Cloverfields Capital Group’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-1,168
Closed -$509K – 102
2023
Q3 		$509K Hold
1,168
– – 0.23% 74
2023
Q2 		$519K Buy
1,168
+420
+56% +$194K 0.17% 75
2023
Q1 		$344K Buy
+748
New +$356K 0.1% 75

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Cloverfields Capital Group's ELV Position: Q4 2023 in Review

Cloverfields Capital Group sold out of Elevance Health (ELV) in Q4 2023, closing a stake of 1,168 shares — an estimated $509K sold.

Cloverfields Capital Group first reported a position in ELV in Q1 2023 and held it in 3 quarters. The position peaked at $519K in Q2 2023. 1,655 funds tracked by Wall St. Rank hold ELV as of Q4 2023.

  • Cloverfields Capital Group reported no remaining Elevance Health position as of Q4 2023 after selling out during the quarter.
  • Cloverfields Capital Group sold 1,168 Elevance Health shares in Q4 2023, an estimated $509K.
  • Cloverfields Capital Group first reported a position in Elevance Health in Q1 2023 and held it in 3 quarters.
  • Cloverfields Capital Group's Elevance Health position peaked at $519K in Q2 2023.
  • 1,655 funds tracked by Wall St. Rank held Elevance Health as of Q4 2023.

Based on Cloverfields Capital Group's 13F filing for Q4 2023, filed 12 Feb 2024.